AAAAAA

   
Results: 1-24 |
Results: 24
IL-3-MEDIATED ENHANCEMENT OF PARTICULATE ANTIGEN PRESENTATION BY MACROPHAGES
Authors: LORD EM YEH KY MORAN JA STOROZYNSKY E FRELINGER JG
Citation: Em. Lord et al., IL-3-MEDIATED ENHANCEMENT OF PARTICULATE ANTIGEN PRESENTATION BY MACROPHAGES, Journal of immunotherapy, 21(3), 1998, pp. 205-210
REGULATION OF HUMAN PROSTATE-SPECIFIC ANTIGEN GENE-EXPRESSION IN TRANSGENIC MICE - EVIDENCE FOR AN ENHANCER BETWEEN THE PSA AND HUMAN GLANDULAR KALLIKREIN-1 GENES
Authors: WEI CW CALLAHAN BP TURNER MJ WILLIS RA LORD EM BARTH RK FRELINGER JG
Citation: Cw. Wei et al., REGULATION OF HUMAN PROSTATE-SPECIFIC ANTIGEN GENE-EXPRESSION IN TRANSGENIC MICE - EVIDENCE FOR AN ENHANCER BETWEEN THE PSA AND HUMAN GLANDULAR KALLIKREIN-1 GENES, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2(4), 1998, pp. 487-496
A TRANSGENIC STRATEGY FOR ANALYZING THE REGULATORY REGIONS OF THE HUMAN PROSTATE-SPECIFIC ANTIGEN GENE - POTENTIAL APPLICATIONS FOR THE TREATMENT OF PROSTATE-CANCER (REVIEW)
Authors: WILLIS RA WEI CW TURNER MJ CALLAHAN BP PUGH AE BARTH RK LORD EM FRELINGER JG
Citation: Ra. Willis et al., A TRANSGENIC STRATEGY FOR ANALYZING THE REGULATORY REGIONS OF THE HUMAN PROSTATE-SPECIFIC ANTIGEN GENE - POTENTIAL APPLICATIONS FOR THE TREATMENT OF PROSTATE-CANCER (REVIEW), INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(2), 1998, pp. 379-386
THE MHC CLASS-II TRANSACTIVATOR (CIITA) REDUCES TUMORIGENICITY AND IMMUNOGENICITY IN A MURINE LUNG-CARCINOMA MODEL
Authors: MARTIN BK FRELINGER JG TING JPY
Citation: Bk. Martin et al., THE MHC CLASS-II TRANSACTIVATOR (CIITA) REDUCES TUMORIGENICITY AND IMMUNOGENICITY IN A MURINE LUNG-CARCINOMA MODEL, The FASEB journal, 12(4), 1998, pp. 1626-1626
TUMOR-IMMUNOTHERAPY - CYTOKINES AND ANTIGEN PRESENTATION
Authors: LORD EM FRELINGER JG
Citation: Em. Lord et Jg. Frelinger, TUMOR-IMMUNOTHERAPY - CYTOKINES AND ANTIGEN PRESENTATION, Cancer immunology and immunotherapy, 46(2), 1998, pp. 75-81
IL-3 ENHANCES BOTH PRESENTATION OF EXOGENOUS PARTICULATE ANTIGEN IN ASSOCIATION WITH CLASS-I MAJOR HISTOCOMPATIBILITY ANTIGEN AND GENERATION OF PRIMARY TUMOR-SPECIFIC CYTOLYTIC T-LYMPHOCYTES
Authors: YEH KY MCADAM AJ PULASKI BA SHASTRI N FRELINGER JG LORD EM
Citation: Ky. Yeh et al., IL-3 ENHANCES BOTH PRESENTATION OF EXOGENOUS PARTICULATE ANTIGEN IN ASSOCIATION WITH CLASS-I MAJOR HISTOCOMPATIBILITY ANTIGEN AND GENERATION OF PRIMARY TUMOR-SPECIFIC CYTOLYTIC T-LYMPHOCYTES, The Journal of immunology, 160(12), 1998, pp. 5773-5780
INTERLEUKIN-2 EXPRESSION BY TUMOR-CELLS ALTERS BOTH THE IMMUNE-RESPONSE AND THE TUMOR MICROENVIRONMENT
Authors: LEE J FENTON BM KOCH CJ FRELINGER JG LORD EM
Citation: J. Lee et al., INTERLEUKIN-2 EXPRESSION BY TUMOR-CELLS ALTERS BOTH THE IMMUNE-RESPONSE AND THE TUMOR MICROENVIRONMENT, Cancer research, 58(7), 1998, pp. 1478-1485
TISSUE-SPECIFIC EXPRESSION OF THE HUMAN PROSTATE-SPECIFIC ANTIGEN GENE IN TRANSGENIC MICE - IMPLICATIONS FOR TOLERANCE AND IMMUNOTHERAPY
Authors: WEI CW WILLIS RA TILTON BR LOONEY RJ LORD EM BARTH RK FRELINGER JG
Citation: Cw. Wei et al., TISSUE-SPECIFIC EXPRESSION OF THE HUMAN PROSTATE-SPECIFIC ANTIGEN GENE IN TRANSGENIC MICE - IMPLICATIONS FOR TOLERANCE AND IMMUNOTHERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(12), 1997, pp. 6369-6374
ANTI-CD43 INHIBITION OF T-CELL HOMING
Authors: MCEVOY LM SUN HL FRELINGER JG BUTCHER EC
Citation: Lm. Mcevoy et al., ANTI-CD43 INHIBITION OF T-CELL HOMING, The Journal of experimental medicine, 185(8), 1997, pp. 1493-1498
EXPRESSION OF MOUSE CD43 IN THE B-CELL LINEAGE OF TRANSGENIC MICE CAUSES IMPAIRED IMMUNE-RESPONSES TO T-INDEPENDENT ANTIGENS
Authors: OSTBERG JR DRAGONE LL BORRELLO MA PHIPPS RP BARTH RK FRELINGER JG
Citation: Jr. Ostberg et al., EXPRESSION OF MOUSE CD43 IN THE B-CELL LINEAGE OF TRANSGENIC MICE CAUSES IMPAIRED IMMUNE-RESPONSES TO T-INDEPENDENT ANTIGENS, European Journal of Immunology, 27(9), 1997, pp. 2152-2159
DEVELOPMENT OF HUMAN PSA-EXPRESSING TRANSGENIC MICE TO INVESTIGATE TARGETED CTL-MEDIATED IMMUNITY FOR PROSTATE-CANCER
Authors: WEI C BARTH RK WILLIS RA TILTON BR LORD EM FRELINGER JG
Citation: C. Wei et al., DEVELOPMENT OF HUMAN PSA-EXPRESSING TRANSGENIC MICE TO INVESTIGATE TARGETED CTL-MEDIATED IMMUNITY FOR PROSTATE-CANCER, The FASEB journal, 10(6), 1996, pp. 2690-2690
ANALYSIS OF THE CTL RESPONSE TO HUMAN PROSTATE-SPECIFIC ANTIGEN (PSA)IN A MOUSE-TUMOR MODEL - EFFECT OF ENDOGENOUS EXPRESSION OF A PSA TRANSGENE
Authors: WILLIS RA WEI C STOROZYNSKY ES TILTON BM BARTH RK LORD EM FRELINGER JG
Citation: Ra. Willis et al., ANALYSIS OF THE CTL RESPONSE TO HUMAN PROSTATE-SPECIFIC ANTIGEN (PSA)IN A MOUSE-TUMOR MODEL - EFFECT OF ENDOGENOUS EXPRESSION OF A PSA TRANSGENE, The FASEB journal, 10(6), 1996, pp. 2691-2691
GMCSF AND IL-3 ENHANCE EXOGENOUS PRESENTATION OF SOLUBLE AND PARTICULATE ANTIGEN BY SPLENIC DENDRITIC CELLS VIA MHC CLASS-I PATHWAY
Authors: STOROZYNSKY E YEH KY SHASTRI N FRELINGER JG LORD EM
Citation: E. Storozynsky et al., GMCSF AND IL-3 ENHANCE EXOGENOUS PRESENTATION OF SOLUBLE AND PARTICULATE ANTIGEN BY SPLENIC DENDRITIC CELLS VIA MHC CLASS-I PATHWAY, The FASEB journal, 10(6), 1996, pp. 2824-2824
EXPRESSION OF HUMAN PROSTATE-SPECIFIC ANTIGEN (PSA) IN A MOUSE-TUMOR CELL-LINE REDUCES TUMORIGENICITY AND ELICITS PSA-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
Authors: WEI CW STOROZYNSKY E MCADAM AJ YEH KY TILTON BR WILLIS RA BARTH RK LOONEY RJ LORD EM FRELINGER JG
Citation: Cw. Wei et al., EXPRESSION OF HUMAN PROSTATE-SPECIFIC ANTIGEN (PSA) IN A MOUSE-TUMOR CELL-LINE REDUCES TUMORIGENICITY AND ELICITS PSA-SPECIFIC CYTOTOXIC T-LYMPHOCYTES, Cancer immunology and immunotherapy, 42(6), 1996, pp. 362-368
INTERLEUKIN-3 ENHANCES CYTOTOXIC T-LYMPHOCYTE DEVELOPMENT AND CLASS-IMAJOR HISTOCOMPATIBILITY COMPLEX RE-PRESENTATION OF EXOGENOUS ANTIGENBY TUMOR-INFILTRATING ANTIGEN-PRESENTING CELLS
Authors: PULASKI BA YEH KY SHASTRI N MALTBY KM PENNEY DP LORD EM FRELINGER JG
Citation: Ba. Pulaski et al., INTERLEUKIN-3 ENHANCES CYTOTOXIC T-LYMPHOCYTE DEVELOPMENT AND CLASS-IMAJOR HISTOCOMPATIBILITY COMPLEX RE-PRESENTATION OF EXOGENOUS ANTIGENBY TUMOR-INFILTRATING ANTIGEN-PRESENTING CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 93(8), 1996, pp. 3669-3674
DISREGULATED EXPRESSION OF CD43 (LEUKOSIALIN, SIALOPHORIN) IN THE B-CELL LINEAGE LEADS TO IMMUNODEFICIENCY
Authors: OSTBERG JR DRAGONE LL DRISKELL T MOYNIHAN JA PHIPPS R BARTH RK FRELINGER JG
Citation: Jr. Ostberg et al., DISREGULATED EXPRESSION OF CD43 (LEUKOSIALIN, SIALOPHORIN) IN THE B-CELL LINEAGE LEADS TO IMMUNODEFICIENCY, The Journal of immunology, 157(11), 1996, pp. 4876-4884
DISREGULATION OF LEUKOSIALIN (CD43, LY48, SIALOPHORIN) EXPRESSION IN THE B-CELL LINEAGE OF TRANSGENIC MICE INCREASES SPLENIC B-CELL NUMBER AND SURVIVAL
Authors: DRAGONE LL BARTH RK SITAR KL DISBROW GL FRELINGER JG
Citation: Ll. Dragone et al., DISREGULATION OF LEUKOSIALIN (CD43, LY48, SIALOPHORIN) EXPRESSION IN THE B-CELL LINEAGE OF TRANSGENIC MICE INCREASES SPLENIC B-CELL NUMBER AND SURVIVAL, Proceedings of the National Academy of Sciences of the United Statesof America, 92(2), 1995, pp. 626-630
SYNERGISTIC EFFECTS OF COEXPRESSION OF THE TH1 CYTOKINES IL-2 AND IFN-GAMMA ON GENERATION OF MURINE TUMOR-REACTIVE CYTOTOXIC-CELLS
Authors: MCADAM AJ PULASKI BA HARKINS SS HUTTER EK LORD EM FRELINGER JG
Citation: Aj. Mcadam et al., SYNERGISTIC EFFECTS OF COEXPRESSION OF THE TH1 CYTOKINES IL-2 AND IFN-GAMMA ON GENERATION OF MURINE TUMOR-REACTIVE CYTOTOXIC-CELLS, International journal of cancer, 61(5), 1995, pp. 628-634
ANALYSIS OF THE EFFECT OF CYTOKINES (INTERLEUKIN-2, INTERLEUKIN-3, INTERLEUKIN-4, AND INTERLEUKIN-6, GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR, AND INTERFERON-GAMMA) ON GENERATIONS OF PRIMARY CYTOTOXIC T-LYMPHOCYTES AGAINST A WEAKLY IMMUNOGENIC TUMOR
Authors: MCADAM AJ PULASKI BA STOROZYNSKY E YEH KY SICKEL JZ FRELINGER JG LORD EM
Citation: Aj. Mcadam et al., ANALYSIS OF THE EFFECT OF CYTOKINES (INTERLEUKIN-2, INTERLEUKIN-3, INTERLEUKIN-4, AND INTERLEUKIN-6, GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR, AND INTERFERON-GAMMA) ON GENERATIONS OF PRIMARY CYTOTOXIC T-LYMPHOCYTES AGAINST A WEAKLY IMMUNOGENIC TUMOR, Cellular immunology, 165(2), 1995, pp. 183-192
B7-1 ENHANCES NATURAL-KILLER CELL-MEDIATED CYTOTOXICITY AND INHIBITS TUMOR-GROWTH OF A POORLY IMMUNOGENIC MURINE CARCINOMA
Authors: YEH KY PULASKI BA WOODS ML MCADAM AJ GASPARI AA FRELINGER JG LORD EM
Citation: Ky. Yeh et al., B7-1 ENHANCES NATURAL-KILLER CELL-MEDIATED CYTOTOXICITY AND INHIBITS TUMOR-GROWTH OF A POORLY IMMUNOGENIC MURINE CARCINOMA, Cellular immunology, 165(2), 1995, pp. 217-224
TRANSFECTION OF TRANSFORMING GROWTH-FACTOR-BETA PRODUCING TUMOR EMT6 WITH INTERLEUKIN-2 ELICITS TUMOR REJECTION AND TUMOR REACTIVE CYTOTOXIC T-LYMPHOCYTES
Authors: MCADAM AJ FELCHER A WOODS ML PULASKI BA HUTTER EK FRELINGER JG LORD EM
Citation: Aj. Mcadam et al., TRANSFECTION OF TRANSFORMING GROWTH-FACTOR-BETA PRODUCING TUMOR EMT6 WITH INTERLEUKIN-2 ELICITS TUMOR REJECTION AND TUMOR REACTIVE CYTOTOXIC T-LYMPHOCYTES, Journal of immunotherapy with emphasis on tumor immunology, 15(3), 1994, pp. 155-164
INTERLEUKIN-3 INHIBITS THE GENERATION OF NONSPECIFIC KILLERS BY INTERLEUKIN-2
Authors: MCADAM AJ YEH KY PULASKI BA FRELINGER JG LORD EM
Citation: Aj. Mcadam et al., INTERLEUKIN-3 INHIBITS THE GENERATION OF NONSPECIFIC KILLERS BY INTERLEUKIN-2, Journal of immunotherapy with emphasis on tumor immunology, 14(4), 1993, pp. 293-297
ISOLATION AND EXPANSION OF TUMOR-INFILTRATING LYMPHOCYTES
Authors: WOODS ML MCADAM AJ FRELINGER JG LORD EM
Citation: Ml. Woods et al., ISOLATION AND EXPANSION OF TUMOR-INFILTRATING LYMPHOCYTES, BioTechniques, 15(6), 1993, pp. 970-972
INTERLEUKIN-3 ENHANCES DEVELOPMENT OF TUMOR-REACTIVE CYTOTOXIC-CELLS BY A CD4-DEPENDENT MECHANISM
Authors: PULASKI BA MCADAM AJ HUTTER EK BIGGAR S LORD EM FRELINGER JG
Citation: Ba. Pulaski et al., INTERLEUKIN-3 ENHANCES DEVELOPMENT OF TUMOR-REACTIVE CYTOTOXIC-CELLS BY A CD4-DEPENDENT MECHANISM, Cancer research, 53(9), 1993, pp. 2112-2117
Risultati: 1-24 |